Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Department of Health and Human Services, Centers for Disease Control and Prevention,

Department of Health and Human Services, Centers for Disease Control and Prevention, Patent applications
Patent application numberTitlePublished
20110315477ELECTROADHESION DEVICE FOR IMPROVING EXTENSION LADDER STABILITY - A method of stabilizing a ladder is provided by attaching one or more electroadhesive devices to an attachment point on the ladder and contacting the device to a surface such as a wall or the floor. The electrostatic force achieved by applying a voltage difference in the device provides decreased ladder slip angles or increased shear forces required to create ladder slippage thereby improving ladder stability.12-29-2011
20100317034PRIMATE T-LYMPHOTROPIC VIRUSES - Disclosed are compositions and methods related to the isolation and identification of the primate T-lymphotropic viruses, HTLV-3 and HTLV-4. The diversity of HTLVs was investigated among central Africans reporting contact with NHP blood and body fluids through hunting, butchering, and keeping primate pets. Herein it is shown that this population is infected with a variety of HTLVs, including two retroviruses; HTLV-4 is the first member of a novel phylogenetic lineage that is distinct from all known HTLVs and STLVs; HTLV-3 falls within the genetic diversity of STLV-3, a group that has not previously been seen in humans. The present disclosure also relates to vectors and vaccines for use in humans against infection and disease. The disclosure further relates to a variety of bioassays and kits for the detection and diagnosis of infection with and diseases caused by HTLV-3 and HTLV-4 and related viruses.12-16-2010
20100003273NUCLEIC ACID VACCINES FOR PREVENTION OF FLAVIVIRUS INFECTION - The present invention encompasses isolated nucleic acids containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus. The invention further encompasses a nucleic acid and protein vaccine and the use of the vaccine to immunize a subject against flavivirus infection. The invention also provides antigens encoded by nucleic acids of the invention, antibodies elicited in response to the antigens and use of the antigens and/or antibodies in detecting flavivirus or diagnosing flavivirus infection.01-07-2010
20090111089PRIMERS AND PROBES FOR DETECTION AND DISCRIMINATION OF TYPES AND SUBTYPES OF INFLUENZA VIRUSES - Methods of detecting influenza, including differentiating between type and subtype are disclosed, for example to detect, type, and/or subtype an influenza infection. A sample suspected of containing a nucleic acid of an influenza virus, is screened for the presence or absence of that nucleic acid. The presence of the influenza virus nucleic acid indicates the presence of influenza virus. Determining whether the influenza virus nucleic acid is present in the sample can be accomplished by detecting hybridization between an influenza specific probe, influenza type specific probe, and/or subtype specific probe and an influenza nucleic acid. Probes and primers for the detection, typing and/or subtyping of influenza virus are also disclosed. Kits and arrays that contain the disclosed probes and/or primers also are disclosed.04-30-2009

Patent applications by Department of Health and Human Services, Centers for Disease Control and Prevention,